Full Text View
Tabular View
No Study Results Posted
Related Studies
Omega-3 Fatty Acid Treatment in Multiple Sclerosis
This study has been completed.
Study NCT00360906   Information provided by Haukeland University Hospital
First Received: August 4, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Sclerosis
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Triomar™ (omega-3 fatty acids)
Sponsors listed in this trial
Haukeland University Hospital
The Multiple Sclerosis National Competence Centre
The Norwegian Multiple sclerosis Society
Pronova Biocare
Serono Nordic
Amersham Health


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services